LINC00313: A Potential Drug Target and Biomarker (G114038)

Target Name: LINC00313

NCBI ID: G114038

LINC00313

Other Name(s): C21orf84 | NCRNA00313 | CH507-42P11.5 | long intergenic non-protein coding RNA 313 | Long intergenic non-protein coding RNA 313

LINC00313: A Potential Drug Target and Biomarker

LINC00313 (C21orf84) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an attractive target for researchers to study and develop new treatments.

LINC00313 is a small non-coding RNA molecule that is approximately 200 nucleotides in length. It is expressed in a variety of tissues and cells throughout the body and is involved in the regulation of gene expression. It is a good candidate for a drug target because of its small size and the fact that it is expressed in many different tissues and cells.

One of the key features of LINC00313 is its structure. It has a unique five-membered ring structure composed of five nucleotide units. This structure allows it to interact with other molecules and participate in a variety of biological processes. The five-membered structure of LINC00313 enables it to bind to proteins and participate in protein modification and activation. This combination results in LINC00313 having important biological functions within cells.

LINC00313 also has other interesting biological properties. It can specifically bind to certain proteins and modify them. This specific binding makes LINC00313 a very attractive drug target. In addition, LINC00313 can also be expressed in tumor cells, which provides an important tool for studying tumor biology.

The biological properties of LINC00313 make it a promising drug target. Its small size and broad expression allow it to be used to treat a variety of diseases. In addition, the five-membered structure of LINC00313 enables it to bind to a variety of proteins, providing important clues for studying the functions of these proteins. These properties make LINC00313 a very attractive research subject and may bring new hope to medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 313

The "LINC00313 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00313 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets